Explore our solutions
Bispecific antibodies
Unlock the power of dual targeting with our BsAb solutions that can help design, engineer, and optimize your antibody therapeutic to target two distinct sites / markers simultaneously for enhanced efficacy and specificity.
Helping you overcome the challenges seen in dual binding, antibody screening, tissue tropism, pharmacodynamics, analysis, and overall complexity within the process.
Products and Platforms
CHOSOURCE Platform
The CHOSOURCE™ expression platform enables rapid generation of clones expressing high levels of recombinant therapeutic protein during stable cell line development.
Cell Counting & Image Cytometry Instruments
Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables. Together, they provide fast, accurate and efficient ways to assess cell health and viability.
Microplate Readers
As many of you know, microplate readers are instruments used to detect biological, chemical, biochemical or physical events from samples in a microplate.
High Content Screening Instruments
High-Content Analysis (HCA) or High-Content Screening (HCS) combines high-throughput automated imaging and analysis to extract quantitative multi-parametric data at the single-cell level.
Microfluidic Protein Characterization
Proteins differ from each other in their size, molecular structure, and physiochemical properties.
Cellular Imaging Software
Revvity offers sophisticated cellular imaging and analysis software to help you acquire, visualize, analyze and share your image data more effectively and efficiently, so you can spend more time discovering.
In Vivo Imaging
Tracking, monitoring, and visualizing biological processes and disease progression is key to not only helping you better understand biology but also crucial in evaluating the effectiveness of your potential drug candidates earlier in the development process.
Immunoassays
Since their introduction in the 1950’s, immunoassays have been an integral part of research and drug discovery.
Content
Addressing the challenges in modern biotherapeutic development
Addressing the challenges of bispecific antibody characterization with high-throughput platforms
Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics
Streamlining the development of bispecific antibodies from expression to quality assessment with Revvity’s biotherapeutic workflow solutions
Antibody drug conjugates
Revolutionize your therapeutic development with our ADC solutions that can help you discover, develop, and evaluate payload, efficacy and toxicology/safety studies.
Our solutions, including CRISPR tools and screening services, generation of cell models, high-content screening, linker-drug characterization, antibody conjugation, data modelling, potency and detection platforms, and antibody binding and functional assays, can support the precision and reliability required at each stage of your workflow, from discovery through preclinical development.
Products and Platforms
Antibody Drug Conjugate Services
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development.
CHOSOURCE Platform
The CHOSOURCE™ expression platform enables rapid generation of clones expressing high levels of recombinant therapeutic protein during stable cell line development.
Cell Counting & Image Cytometry Instruments
Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables. Together, they provide fast, accurate and efficient ways to assess cell health and viability.
Immunoassays
Since their introduction in the 1950’s, immunoassays have been an integral part of research and drug discovery.
High Content Screening Instruments
High-Content Analysis (HCA) or High-Content Screening (HCS) combines high-throughput automated imaging and analysis to extract quantitative multi-parametric data at the single-cell level.
Microfluidic Protein Characterization
Proteins differ from each other in their size, molecular structure, and physiochemical properties.
Signals
Simplify data capture, processing, and analysis at each ADC development stage, and identify the most promising antibodies, linkers, and payloads.
Content
Antibody drug conjugates: A novel targeted approach to cancer therapy
The steady rise in antibody-drug conjugate (ADC) candidates over the past couple of decades reflects the increasing recognition of their potential in
Preclinical screening platforms for antibody-drug conjugate therapeutics
RNA vaccines and therapeutics
Enhance your RNA therapeutics and vaccine workflows with solutions that can help you produce a safer and efficient approach. With the right support and expertise benefit from the versatility and ease of adaptability a mRNA or other RNA modality platforms can provide.
We can help in target identification, characterization, assay development for early-stage research and screening, as well as preclinical development workflows including evaluation of immunogenicity to support your modality’s efficacy and safety. Our tools and services can address your RNA payload evaluation, optimization and delivery.
Products and Platforms
Microfluidic Nucleic Acid Analysis
Now you can simplify traditional gel separations, while improving the reproducibility of your data in a fraction of the time.
Lentivirus
Lentiviruses are a subtype of retroviruses which have a single stranded RNA genome that encode for three major structural genes: gag, pol, and env.
AAV
Our high-quality premade AAV particles are ideal for pilot studies, or as standardized test material for product, process, or assay development.
RNA Interference
Dharmacon™ siRNA, shRNA, and microRNA-based reagents, leading the field for nearly 30 years providing highly specific and efficient gene silencing.
Oligonucleotide Custom Synthesis
Leveraging almost 30 years of experience as a leading provider in oligo design and synthesis, Revvity's oligo synthesis team offers a range of services.
Immunoassays
Since their introduction in the 1950’s, immunoassays have been an integral part of research and drug discovery.
Microplate Readers
As many of you know, microplate readers are instruments used to detect biological, chemical, biochemical or physical events from samples in a microplate.
Content
An emerging therapeutic modality - RNA carves its path out of the paradigm
Rethinking the vaccine landscape
Novel RNA therapeutic modalities
Explore the various modalities and advances in therapy that have been enabled by RNA.